Retraction Watch

Tracking retractions as a window into the scientific process

Archive for the ‘molecular cancer therapeutics’ Category

ORI sanctions former University of Chicago and UCSF scientists for faking findings

with 11 comments

H. Rosie Xing

H. Rosie Xing

The stories behind several recent inscrutable retraction notices became a bit more clear today when the Office of Research Integrity (ORI) issued findings in cases involving former researchers at the University of Chicago and the University of California, San Francisco.

The ORI found that H. Rosie Xing, a former assistant professor at the University of Chicago, Read the rest of this entry »

A “retraction in part” for Anil Potti and colleagues, in Molecular Cancer Therapeutics

with one comment

A partial retraction has joined the ten retractions and five corrections of Anil Potti’s papers, this one of a 2008 paper in Molecular Cancer Therapeutics. The move comes 14 months after the retraction of the Nature Medicine paper upon which much of the Molecular Cancer Therapeutics paper was based.

Here’s the notice: Read the rest of this entry »